(Alliance News) -Â Omega Diagnostics Group PLC on Monday said it is continuing to modify its Alva-based facility to "upscale significantly" its lateral flow test production capacity as it noted a Financial Times article.
The FT said the UK government has chosen three British companies to make rapid Covid-19 tests. The newspaper said Omega, SureScreen and Global Access Diagnostics have been selected by the Department of Health to produce up to 2 million lateral flow devices per day for the UK, according to two people briefed on the decision.
https://www.ft.com/content/37011547-c7b1-403b-abfd-9b3e554fb4b2
Omega in a statement on Monday said: "The company can confirm that it is continuing to modify its Alva-based facility to upscale significantly its lateral flow test production capacity. When contracts or supply agreements are signed to utilise this capacity the company will announce this in line with AIM disclosure obligations."
Shares in the medical diagnostics company were up 27% at 87.77 pence in London on Monday.
By Lucy Heming;Â lucyheming@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
